Clinical Trial Update: Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous ferric carboxymaltose for hemoglobin response and transfusion needs in iron deficiency anemia patients after off-pump coron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN